The pattern of collagen production may contribute to the gluteal muscle contracture pathogenic process.


Journal

Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112

Informations de publication

Date de publication:
08 Aug 2023
Historique:
received: 15 05 2023
accepted: 02 08 2023
medline: 9 8 2023
pubmed: 8 8 2023
entrez: 7 8 2023
Statut: epublish

Résumé

Arthroscopic release is now the gold standard globally for gluteal muscle contracture (GMC) treatment. However, some patients fail to improve after the first operation and are forced to undergo a second operation. This study explores the essential role collagen fibers may play in muscle contracture in GMC. From February 2010 to May 2018, 1041 hips of 543 GMC patients underwent arthroscopic release. Among them, 498 (91.7%) patients had bilateral GMC and were admitted to the retrospective cohort study. Pathological testing and type III collagen testing were used in contracture tissue studies. Single-cell RNA-sequencing analysis was applied to explore the role of fibroblasts in muscle repair. Compared with GMC II patients, GMC III patients displayed higher clinical symptoms (P < 0.05). Six weeks after the surgery, the patients in GMC II had a lower prominent hip snap rate, higher JOA score, and better hip range of motion (P < 0.05). Compared with normal muscle tissue, contracture-affected tissue tended to have more type III collagen and form shorter fibers. Recurrent GMC patients seemed to have a higher type III collagen ratio (P < 0.05). In contrast to normally repairable muscle defects, fibroblasts in non-repairable defects were shown to downregulate collagen-related pathways at the early and late stages of tissue repair. This study describes the arthroscopic release of GMC. Study findings include the suggestion that the collagen secretion function of fibroblasts and collagen pattern might influence the muscle repair ability and be further involved in the GMC pathogenic process.

Identifiants

pubmed: 37550712
doi: 10.1186/s13018-023-04069-w
pii: 10.1186/s13018-023-04069-w
pmc: PMC10408206
doi:

Substances chimiques

Collagen Type III 0
Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

579

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Cell Tissue Res. 2016 Jun;364(3):647-660
pubmed: 26742767
Front Physiol. 2020 Mar 19;11:253
pubmed: 32265741
Innovation (Camb). 2021 Jul 01;2(3):100141
pubmed: 34557778
SICOT J. 2017;3:1
pubmed: 28059055
Gene. 2019 Jul 30;707:151-171
pubmed: 31075413
Am J Physiol Cell Physiol. 2013 Aug 1;305(3):C241-52
pubmed: 23761627
Skelet Muscle. 2011 May 04;1(1):21
pubmed: 21798099
Int Orthop. 2017 Aug;41(8):1521-1526
pubmed: 27900442
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 Mar;33(3):274-6
pubmed: 18382066
J Pediatr Orthop. 2015 Mar;35(2):192-8
pubmed: 24992345
Cell Tissue Res. 2019 Mar;375(3):575-588
pubmed: 30421315
Nat Biotechnol. 2015 May;33(5):495-502
pubmed: 25867923
Zhonghua Wai Ke Za Zhi. 2008 Jul 1;46(13):970-2
pubmed: 19035194
J Bone Joint Surg Am. 2019 Feb 20;101(4):361-368
pubmed: 30801376
Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2111445119
pubmed: 35377804
J Pediatr Orthop. 2021 Mar 1;41(3):e240-e245
pubmed: 33481480
Arch Phys Med Rehabil. 2008 Jun;89(6):1146-54
pubmed: 18503813
J Orthop Sci. 2010 Jul;15(4):452-8
pubmed: 20721711
J Physiol. 2021 Feb;599(3):943-962
pubmed: 33247944
J Pediatr Orthop. 2011 Jul-Aug;31(5):e38-43
pubmed: 21654446
BMC Musculoskelet Disord. 2010 Jan 25;11:15
pubmed: 20100316
Skeletal Radiol. 2011 Feb;40(2):215-21
pubmed: 20140430
Clin Orthop Relat Res. 2009 Mar;467(3):799-804
pubmed: 18975040
J Tongji Med Univ. 2000;20(1):70-1
pubmed: 12845763
Zhongguo Gu Shang. 2013 Jun;26(6):468-70
pubmed: 24015650
BMC Musculoskelet Disord. 2017 Mar 16;18(1):113
pubmed: 28302115
Int Rev Cytol. 2007;257:143-79
pubmed: 17280897
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
BMC Musculoskelet Disord. 2009 Apr 07;10:34
pubmed: 19351391
J Pediatr Orthop B. 2014 Sep;23(5):435-40
pubmed: 24887050
Matrix Biol. 2018 Dec;74:77-100
pubmed: 29981373
Orthopedics. 2012 Dec;35(12):e1692-8
pubmed: 23218623

Auteurs

Xiaocheng Jiang (X)

Peking University Shenzhen Hospital, Shenzhen City, China.

Hang Zhang (H)

Peking University Shenzhen Hospital, Shenzhen City, China.

Yuxiang Ren (Y)

Peking University Shenzhen Hospital, Shenzhen City, China.

Li Yang (L)

Peking University Shenzhen Hospital, Shenzhen City, China.

Ling Zhong (L)

Peking University Shenzhen Hospital, Shenzhen City, China.

Jiang Guo (J)

Peking University Shenzhen Hospital, Shenzhen City, China. guoj223@mail2.sysu.edu.cn.

Xintao Zhang (X)

Peking University Shenzhen Hospital, Shenzhen City, China. zhangxintao@sina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH